Cero Therapeutics Holdings, Stock Widgets and Gadgets
| CERO Stock | 0.06 0.01 19.00% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- CERO CERo Therapeutics Holdings,
- Latest Disposition of 2998908 shares by Yk Bioventures Opportunities Gp I, Llc of CERo Therapeutics at 0.06 subject to Rule 16b-3
- CERO 0.06 -0.0133
- Low 0.0553
- High 0.0707
- Volume 27.6 M
- Alpha 1.38
- Beta 0.89
- Return On Asset -0.45
- Current Valuation 12.73 M
- Shares Outstanding 51.35 M
- Shares Owned By Insiders 12.54 %
- Shares Owned By Institutions 9.04 %
- Number Of Shares Shorted 5.83 M
- EBITDA (2.44 M)
- Net Income (2.54 K)
- Total Debt 1.55 M
- Book Value Per Share (0.52) X
- Cash Flow From Operations (1.52 K)
- Short Ratio 0.23 X
- Earnings Per Share (1.19) X
- Number Of Employees 8
- Beta -0.44
- Market Capitalization 4.79 M
- Total Asset 8.56 M
- Retained Earnings (14.2 M)
- Working Capital 5.91 M
- Net Asset 8.56 M
- Accumulation Distribution 6 M
- Daily Balance Of Power (0.86)
- Rate Of Daily Change 0.81
- Day Median Price 0.063
- Day Typical Price 0.0609
- Price Action Indicator (0.01)
- Period Momentum Indicator (0.01)
Market Snapshot Widget Example
DAX Index Germany | 20,406 0.1 | |
Taiwan Weighted Taiwan | 23,020 0.11 | |
PSI 20 Stock Portugal | 6,354 0.11 | |
CROBEX Croatia | 3,194 0.13 | |
Budapest SE Hungary | 80,166 0.46 | |
IDX 30 Jakarta Indonesia | 443.33 1.05 | |
ISEQ 20 Price Ireland | 1,648 0.0006 | |
NYSE Comp USA | 19,729 0.2 | |
Tel Aviv 35 Israel | 2,335 0.04 | |
Coreshares Index Tracker South Afric | 1,098 1.29 | |
IPC MEXICO Mexico | 51,653 0.70 | |
KL Technology Malaysia | 63.70 2.18 | |
IBEX 35 Index Spain | 11,752 0.11 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,648 0.28 | |
SPASX Dividend Opportunities Australia | 1,680 0.49 | |
HNX 30 Vietnam | 480.47 0.88 | |
Bucharest BET-NG Romania | 1,242 0.37 | |
AMS Small Cap Netherlands | 1,240 0.14 | |
Oslo Exchange Mutual Norway | 1,405 0.14 | |
BEL Small Belgium | 8,042 0.12 | |
Basic Materials Brazil | 5,772 2.08 | |
Swiss Leader Price Switzerland | 1,937 0.28 | |
Fondo Mutuo ETF Chile | 1,408 0.26 | |
Athens General Comp Greece | 1,469 0.36 | |
Stock Exchange Of Thailand | 1,432 0.57 | |
PX Prague Stock Czech Repub | 1,739 0.96 | |
THE PHILIPPINE STOCK Philippines | 6,617 0.37 | |
WIG 30 Poland | 2,896 0.14 | |
BIST Electricity Turkey | 514.73 0.73 |
Investing Ideas
In addition to having CERo Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare CERo Therapeutics
Compare CERo Therapeutics To Peers
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CERo Therapeutics Holdings,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CERo Therapeutics. If investors know CERo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CERo Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.19) | Return On Assets (0.45) |
The market value of CERo Therapeutics is measured differently than its book value, which is the value of CERo that is recorded on the company's balance sheet. Investors also form their own opinion of CERo Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is CERo Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CERo Therapeutics' market value can be influenced by many factors that don't directly affect CERo Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CERo Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if CERo Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CERo Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.